Taiwan FDA registration 75b4555d027ff763aee898d51798c0b7
Glucotest Prime Blood Glucose Monitoring System
TW: “衡欣” 基普血糖測試系統
Taiwan·Risk Class 2·MD·Hengxin Medical Equipment Co., Ltd·Registered Jan 18, 2017 – Jan 19, 2022CancelledRegistration details
- Analysis ID
- 75b4555d027ff763aee898d51798c0b7
- License Form
- Ministry of Health Medical Device Manufacturing No. 005370
Company information
- Manufacturer
- Hengxin Medical Equipment Co., Ltd
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Hengxin Medical Equipment Co., Ltd
Product details
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1345 Glucose Test System
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Jan 18, 2017
- Expiry Date
- Jan 19, 2022
- Cancellation Date
- Jun 20, 2022
Cancellation information
- Status
- Logged out
- Reason
- 自請註銷
About this record
Access comprehensive regulatory information for Glucotest Prime Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 75b4555d027ff763aee898d51798c0b7 and manufactured by Hengxin Medical Equipment Co., Ltd. The authorized representative in Taiwan is Hengxin Medical Equipment Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices